The Geras virtual frailty rehabilitation program to build resilience in older adults with frailty during COVID-19: a randomized feasibility trial.

Chinenye Okpara, George Ioannidis, Lehana Thabane, Jonathan Derrick Adachi, Alexander Rabinovich, Patricia Hewston, Justin Lee, Caitlin McArthur, Courtney Kennedy, Tricia Woo, Pauline Boulos, Raja Bobba, Mimi Wang, Samuel Thrall, Derelie Mangin, Sharon Marr, David Armstrong, Christopher Patterson, Steven Bray, Kerstin de Wit, Shyam Maharaj, Brian Misiaszek, Jessica Belgrave Sookhoo, Karen Thompson, Alexandra Papaioannou
Author Information
  1. Chinenye Okpara: Department of Health Research Methodology, Evidence and Impact, McMaster University, Hamilton, ON, Canada. okparc1@mcmaster.ca. ORCID
  2. George Ioannidis: Department of Health Research Methodology, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
  3. Lehana Thabane: Department of Health Research Methodology, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
  4. Jonathan Derrick Adachi: Department of Medicine, McMaster University, Hamilton, ON, Canada.
  5. Alexander Rabinovich: Department of Surgery, McMaster University, Hamilton, ON, Canada.
  6. Patricia Hewston: Geras Centre for Aging Research, Hamilton Health Sciences, Hamilton, ON, Canada.
  7. Justin Lee: Geras Centre for Aging Research, Hamilton Health Sciences, Hamilton, ON, Canada.
  8. Caitlin McArthur: Geras Centre for Aging Research, Hamilton Health Sciences, Hamilton, ON, Canada.
  9. Courtney Kennedy: Geras Centre for Aging Research, Hamilton Health Sciences, Hamilton, ON, Canada.
  10. Tricia Woo: Geras Centre for Aging Research, Hamilton Health Sciences, Hamilton, ON, Canada.
  11. Pauline Boulos: Department of Medicine, McMaster University, Hamilton, ON, Canada.
  12. Raja Bobba: Department of Medicine, McMaster University, Hamilton, ON, Canada.
  13. Mimi Wang: Department of Medicine, McMaster University, Hamilton, ON, Canada.
  14. Samuel Thrall: Department of Medicine, McMaster University, Hamilton, ON, Canada.
  15. Derelie Mangin: Department of Family Medicine, McMaster University, Hamilton, ON, Canada.
  16. Sharon Marr: Department of Medicine, University of Toronto, Hamilton, ON, Canada.
  17. David Armstrong: Department of Medicine, McMaster University, Hamilton, ON, Canada.
  18. Christopher Patterson: Department of Medicine, McMaster University, Hamilton, ON, Canada.
  19. Steven Bray: Department of Kinesiology, McMaster University, Hamilton, ON, Canada.
  20. Kerstin de Wit: Department of Emergency Medicine, Queen's University, Kingston, ON, Canada.
  21. Shyam Maharaj: Department of Medicine, McMaster University, Hamilton, ON, Canada.
  22. Brian Misiaszek: Department of Medicine, McMaster University, Hamilton, ON, Canada.
  23. Jessica Belgrave Sookhoo: Geras Centre for Aging Research, Hamilton Health Sciences, Hamilton, ON, Canada.
  24. Karen Thompson: Geras Centre for Aging Research, Hamilton Health Sciences, Hamilton, ON, Canada.
  25. Alexandra Papaioannou: Department of Health Research Methodology, Evidence and Impact, McMaster University, Hamilton, ON, Canada.

Abstract

BACKGROUND: The Coronavirus (COVID-19) pandemic has exacerbated the risk for poor physical and mental health outcomes among vulnerable older adults. Multicomponent interventions could potentially prevent or reduce the risk of becoming frail; however, there is limited evidence about utilizing alternative modes of delivery where access to in-person care may be challenging. This randomized feasibility trial aimed to understand how a multicomponent rehabilitation program can be delivered remotely to vulnerable older adults with frailty during the pandemic.
METHODS: Participants were randomized to either a multimodal or socialization arm. Over a 12-week intervention period, the multimodal group received virtual care at home, which included twice-weekly exercise in small group physiotherapy-led live-streamed sessions, nutrition counselling and protein supplementation, medication consultation via a videoconference app, and once-weekly phone calls from student volunteers, while the socialization group received only once-weekly phone calls from the volunteers. The RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance) framework was used to evaluate the feasibility of the program. The main clinical outcomes were change in the 5-times sit-to-stand test (5��������STS) and Depression, Anxiety and Stress Scale (DASS-21) scores. The feasibility outcomes were analyzed using descriptive statistics and expressed as frequencies and mean percent with corresponding confidence intervals (CI). Analysis of covariance (ANCOVA) was used for the effectiveness component.
RESULTS: The program enrolled 33% (n���=���72) of referrals to the study (n���=���220), of whom 70 were randomized. Adoption rates from different referral sources were community self-referrals (60%), community organizations (33%), and healthcare providers (25%). At the provider level, implementation rates varied from 75 to 100% for different aspects of program delivery. Participant's adherence levels included virtual exercise sessions 81% (95% CI: 75-88%), home-based exercise 50% (95% CI: 38-62%), protein supplements consumption 68% (95% CI: 55-80%), and medication optimization 38% (95% CI: 21-59%). Most participants (85%) were satisfied with the program. There were no significant changes in clinical outcomes between the two arms.
CONCLUSION: The GERAS virtual frailty rehabilitation study for community-dwelling older adults living with frailty was feasible in terms of reach of participants, adoption across referral settings, adherence to implementation, and participant's intention to maintain the program. This program could be feasibly delivered to improve access to socially isolated older adults where barriers to in-person participation exist. However, trials with larger samples and longer follow-up are required to demonstrate effectiveness and sustained behavior change.
TRIAL REGISTRATION: ClinicalTrials.gov NCT04500366. Registered August 5, 2020, https://clinicaltrials.gov/ct2/show/NCT04500366.

Keywords

Associated Data

ClinicalTrials.gov | NCT04500366

References

  1. CMAJ Open. 2021 Feb 17;9(1):E107-E114 [PMID: 33597307]
  2. J Vestib Res. 2006;16(4-5):233-43 [PMID: 17538213]
  3. Int J Behav Nutr Phys Act. 2019 Dec 2;16(1):119 [PMID: 31791364]
  4. J Am Geriatr Soc. 2019 Apr;67(4):674-694 [PMID: 30693946]
  5. Nutrients. 2020 Nov 30;12(12): [PMID: 33266217]
  6. Trials. 2020 Jun 05;21(1):478 [PMID: 32498690]
  7. J Nutr Health Aging. 2019;23(9):771-787 [PMID: 31641726]
  8. Ageing Res Rev. 2021 Aug;69:101368 [PMID: 34022464]
  9. J Med Internet Res. 2020 Oct 26;22(10):e22810 [PMID: 33104015]
  10. J Am Med Dir Assoc. 2020 Jul;21(7):992-993 [PMID: 32553491]
  11. Arch Phys Med Rehabil. 2003 Jun;84(6):890-7 [PMID: 12808544]
  12. J Appl Gerontol. 2021 Nov;40(11):1649-1658 [PMID: 33402043]
  13. Lancet. 2013 Mar 2;381(9868):752-62 [PMID: 23395245]
  14. Age Ageing. 2008 Jul;37(4):430-5 [PMID: 18487264]
  15. J Am Med Dir Assoc. 2019 Mar;20(3):340-346 [PMID: 30366759]
  16. Exp Gerontol. 2022 Mar;159:111675 [PMID: 34954282]
  17. Qual Life Res. 2019 Sep;28(9):2325-2339 [PMID: 30937732]
  18. JMIR Aging. 2021 Apr 12;4(2):e26474 [PMID: 33720839]
  19. Aging Ment Health. 2022 Oct;26(10):2120-2127 [PMID: 34806487]
  20. J Clin Med. 2021 Nov 26;10(23): [PMID: 34884265]
  21. Age Ageing. 2010 Mar;39(2):228-33 [PMID: 20075036]
  22. Nutr Rev. 2021 Jul 7;79(8):889-913 [PMID: 33330911]
  23. BMJ Open. 2020 Dec 13;10(12):e040146 [PMID: 33318114]
  24. CMAJ. 2005 Aug 30;173(5):489-95 [PMID: 16129869]
  25. J Med Internet Res. 2020 Jun 5;22(6):e17884 [PMID: 32501275]
  26. Health Rep. 2013 Sep;24(9):10-7 [PMID: 24258362]
  27. J Nutr Health Aging. 2020;24(9):938-947 [PMID: 33155618]
  28. J Nutr Health Aging. 2021;25(6):751-756 [PMID: 34179929]
  29. Soc Sci Med. 2014 Nov;120:57-66 [PMID: 25222136]
  30. BMJ. 2016 Oct 24;355:i5239 [PMID: 27777223]
  31. J Telemed Telecare. 2022 Apr;28(3):162-176 [PMID: 32517544]
  32. CMAJ. 2021 Feb 8;193(6):E200-E210 [PMID: 33558406]
  33. Aging Clin Exp Res. 2008 Oct;20(5):479-86 [PMID: 19039291]
  34. J Aging Phys Act. 2021 Aug 13;30(1):148-152 [PMID: 34388700]
  35. PLoS One. 2015 Mar 12;10(3):e0120144 [PMID: 25764521]
  36. BMJ. 2014 Mar 07;348:g1687 [PMID: 24609605]
  37. Br J Sports Med. 2017 Dec;51(24):1750-1758 [PMID: 27707740]
  38. J Am Med Dir Assoc. 2021 Sep;22(9):1802-1812.e21 [PMID: 34000266]
  39. Geriatr Gerontol Int. 2021 Aug;21(8):754-755 [PMID: 34216187]
  40. BMC Public Health. 2019 Nov 8;19(1):1487 [PMID: 31703655]
  41. Expert Rev Clin Pharmacol. 2020 Jan;13(1):15-22 [PMID: 31790317]
  42. J R Coll Physicians Edinb. 2012;42(4):333-40 [PMID: 23240122]
  43. Prev Med. 2012 Oct;55(4):262-275 [PMID: 22813920]
  44. J Am Med Dir Assoc. 2013 Jun;14(6):392-7 [PMID: 23764209]
  45. J Adv Nurs. 2022 Mar;78(3):609-644 [PMID: 34625997]
  46. Am J Med. 1985 Jan;78(1):77-81 [PMID: 3966492]
  47. Am J Med. 2015 Nov;128(11):1225-1236.e1 [PMID: 26159634]
  48. Am J Public Health. 1999 Sep;89(9):1322-7 [PMID: 10474547]
  49. J Geriatr Phys Ther. 2018 Jan/Mar;41(1):49-61 [PMID: 27362526]
  50. Prev Sci. 2021 Nov;22(8):1048-1059 [PMID: 33742266]
  51. Eur Geriatr Med. 2020 Apr;11(2):233-238 [PMID: 32297191]
  52. Front Med (Lausanne). 2017 Nov 27;4:208 [PMID: 29250523]
  53. Health Promot Int. 2016 Jun;31(2):450-8 [PMID: 25715801]
  54. Phys Ther. 2021 Jan 4;101(1): [PMID: 33284318]
  55. PLoS One. 2022 Jan 27;17(1):e0263053 [PMID: 35085330]
  56. Int J Environ Res Public Health. 2021 Feb 11;18(4): [PMID: 33670270]
  57. J Am Geriatr Soc. 1996 Nov;44(11):1332-41 [PMID: 8909349]
  58. Int J Ment Health Addict. 2023;21(1):28-36 [PMID: 34220384]
  59. Rejuvenation Res. 2013 Apr;16(2):105-14 [PMID: 23327448]
  60. BMC Med Inform Decis Mak. 2016 Sep 15;16(1):120 [PMID: 27630020]
  61. J Physiother. 2017 Jan;63(1):40-44 [PMID: 27993489]
  62. Front Public Health. 2019 Mar 29;7:64 [PMID: 30984733]
  63. Nutrients. 2020 Sep 15;12(9): [PMID: 32942634]
  64. J Geriatr Phys Ther. 2007;30(2):69-78 [PMID: 18171490]
  65. BMJ Open. 2015 Dec 09;5(12):e009235 [PMID: 26656020]
  66. Lancet Healthy Longev. 2020 Oct;1(1):e12 [PMID: 34173613]

Word Cloud

Created with Highcharts 10.0.0programolderadultsoutcomesrandomizedfeasibilityrehabilitationvirtual95%CI:frailtygroupexerciseCOVID-19pandemicriskvulnerabledeliveryaccessin-personcaretrialdeliveredmultimodalsocializationreceivedincludedsessionsproteinmedicationonce-weeklyphonecallsvolunteersAdoptionusedclinicalchangeeffectiveness33%studyratesdifferentreferralcommunityimplementationadherenceparticipantsBACKGROUND:CoronavirusexacerbatedpoorphysicalmentalhealthamongMulticomponentinterventionspotentiallypreventreducebecomingfrailhoweverlimitedevidenceutilizingalternativemodesmaychallengingaimedunderstandmulticomponentcanremotelyfrailty duringMETHODS:Participantseitherarm12-weekinterventionperiodhometwice-weeklysmallphysiotherapy-ledlive-streamednutritioncounsellingsupplementationconsultationviavideoconferenceappstudentRE-AIMReachEffectivenessImplementationMaintenanceframeworkevaluatemain5-timessit-to-standtest5��������STSDepressionAnxietyStressScaleDASS-21scoresanalyzedusingdescriptivestatisticsexpressedfrequenciesmeanpercentcorrespondingconfidenceintervalsCIAnalysiscovarianceANCOVAcomponentRESULTS:enrolledn���=���72referralsn���=���22070sourcesself-referrals60%organizationshealthcareproviders25%providerlevelvaried75100%aspectsParticipant'slevels81%75-88%home-based50%38-62%supplementsconsumption68%55-80%optimization38%21-59%85%satisfiedsignificantchangestwoarmsCONCLUSION:GERAScommunity-dwellinglivingfeasibletermsreachadoptionacrosssettingsparticipant'sintentionmaintainfeasiblyimprovesociallyisolatedbarriersparticipationexistHowevertrialslargersampleslongerfollow-uprequireddemonstratesustainedbehaviorTRIALREGISTRATION:ClinicalTrialsgovNCT04500366RegisteredAugust52020https://clinicaltrialsgov/ct2/show/NCT04500366Gerasbuildresilienceadults withCOVID-19:FeasibilitystudiesFrailtyOlderVirtual

Similar Articles

Cited By

No available data.